Famous cosmetics brand Johnson & Johnson lost its license to have canceled Johnson & Johnson India's license to produce the product in Mulund, India. This was decided by the Indian Food and Drug Administration after the discovery of 15 batches of talcum powder for children in which the presence of a very dangerous carcinogenic and highly irritating component, ethylene oxide, was detected. The order will come into effect from June 24th.
Don't store avocado like this: it's dangerous
Dangerous baby products. The famous cosmetic brand Johnson & Johnson lost its license to produce the product at the Mulund plant, suburb of Bomaby in India. This was decided by the Indian Food and Drug Administration, after the discovery dating back to 2007 of 15 lots of baby powder in which the presence of a very dangerous carcinogenic and highly irritating component, ethylene oxide, has been detected. The order will come into force starting from 24 June next and, in the meantime, the company has 90 days to appeal.
"Ethylene oxide can legally be used for sterilization, but the company hasn't bothered to test after the process to check the residual quantities present in the product. And the products are used for babies. The company must take all possible precautions ", he said KB Shende of the FDA. “We are committed to producing products that meet the quality standards followed by all of our global manufacturing sites and all local high safety regulatory standards. We are working diligently with the agency to solve this problem ", said a spokesman for the multinational, already challenged by the animal rights movement for its massive animal testing activity.
At Mulund, the company produces talcum powder, Band-Aid adhesive bandages and sanitary napkins. A spokesperson for J&J confirmed the FDA's order, which only covered cosmetic products. For this the company will be able to continue manufacturing non-cosmetic products on the same site. "The matter in question - explains the spokesperson - as quoted by the late FDA, refers to a limited number of batches produced in 2007. The FDA has raised concern about ethylene oxide treatment, which was not included as part of the manufacturing process submitted to the FDA. This method is widely used for medical devices around the world. This was followed as an exception and all internal security protocols were followed to ensure that consumer safety was not compromised. Additionally, we ascertained that there were no complaints or reported unexpected / undesirable effects regarding any of the affected batches ”.
In light of these evidences Enpa asks that our Ministry of Health prepare "immediately accurate checks on these products also in our country and that, even more so because they are products intended for children, should they be found dangerous substances for health, adequately provide for withdrawal from the market. However, it is a very good rule do not buy multinational products who have always carried out as useless as barbaric experimentation on animals and instead prefer companies that have always chosen to combine the quality of their products with ethics and respect for people, animals and the environment ".
Che what is ethylene oxide? It is a compound used in large-scale chemical production, which, at room temperature, is very dangerous. This chemical is flammable, carcinogenic, mutagenic and irritating. In short, an unprotected and constant exposure can cause genetic mutations or DNA alterations. It can damage the lungs and cardiovascular system. Physical manifestations after exposure include headache, vomiting, dizziness, sleep disturbance, leg pain, weakness, stiffness, sweating or liver enlargement.
Roberta Ragni
READ also:
- Phenoxyethanol in cosmetics: we protect children, appeal to Procter & Gamble and Unilever
